• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

MSL Board

This board is for Medical Science Liasons in the pharmaceutical industry.
Replies
18
Views
11K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
1K
anonymous
Replies
3
Views
3K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
9
Views
21K
Anonymous
Replies
3
Views
6K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
4
Views
4K
Anonymous
Replies
0
Views
2K
MSL123
Replies
7
Views
4K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
7
Views
7K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
8
Views
4K
Anonymous